Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380291194> ?p ?o ?g. }
- W4380291194 endingPage "3151" @default.
- W4380291194 startingPage "3131" @default.
- W4380291194 abstract "Uveal melanoma (UVM), the leading type of intraocular malignant tumor in adults, has an aggressive course with poor prognoses, high mortality, and lacking effective therapeutic targets and prognostic markers. Annexins are well known as dysregulated and correlated with aggressiveness and prognosis of various cancers. However, little is known about the expression pattern of Annexins in UVM and their prognostic value. This study aimed to investigate and verify the role of Annexins in the pathogenesis of metastatic UVM.The mRNA expression of Annexins in UVM was analyzed from The Cancer Genome Atlas (TCGA) database and validated in three independent datasets (GSE22138, GSE27831, and GSE156877). The bioinformatics analysis and experimental verification of ANXA2 expression in UVM were performed to evaluate its influence on clinical prognosis, cell proliferation, migration, and invasion.Prognostic analysis suggested that high ANXA2/4 expression levels were significantly correlated with worse overall survival (OS), progress-free interval (PFI), and metastasis-free survival (MFS) prognoses. Meanwhile, the prognostic model (ANXA2/4) was built using the PFI-based LASSO analysis in TCGA-UVM and validated in GSE22138 and GSE27831. Multivariate Cox regression analyses indicated that the ANXA2/4 model is an independent prognostic factor associated with UVM. The expression analysis confirmed that ANXA2 was upregulated in metastatic patients. Then, ANXA2 mRNA was confirmed positive and expressed higher in four human UVM cell lines compared with ARPE19 cells, especially in two highly invasive metastatic types (C918 and MUM2B). Moreover, silencing ANXA2 blocked cell proliferation, migration, and invasion abilities of C918 and MUM2B while upregulating ANXA2 enhanced these cell functions remarkably in vitro, suggesting that ANXA2 had a positive effect on malignant biological properties of UVM cells. In addition, flow cytometry analysis showed that the knockdown of ANXA2 had a higher apoptotic rate than the control groups in C918 and MUM2B cells. ANXA2 overexpression had a lower apoptotic rate than those in the control group in OCM-1. In addition, ANXA2 expression had significant correlations with the tumor microenvironment and multiple tumor-infiltrating immune cells.ANXA2 is a novel potential prognostic biomarker for the metastatic diagnosis of UVM." @default.
- W4380291194 created "2023-06-13" @default.
- W4380291194 creator A5031451764 @default.
- W4380291194 creator A5033632697 @default.
- W4380291194 creator A5066684292 @default.
- W4380291194 creator A5071473475 @default.
- W4380291194 date "2023-01-01" @default.
- W4380291194 modified "2023-09-26" @default.
- W4380291194 title "Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma." @default.
- W4380291194 cites W1536396357 @default.
- W4380291194 cites W1821729734 @default.
- W4380291194 cites W2046445536 @default.
- W4380291194 cites W2066310864 @default.
- W4380291194 cites W2084823216 @default.
- W4380291194 cites W2097360283 @default.
- W4380291194 cites W2130410032 @default.
- W4380291194 cites W2130430382 @default.
- W4380291194 cites W2145261833 @default.
- W4380291194 cites W2159707944 @default.
- W4380291194 cites W2160360616 @default.
- W4380291194 cites W2286968366 @default.
- W4380291194 cites W2462064254 @default.
- W4380291194 cites W2463540041 @default.
- W4380291194 cites W2728912974 @default.
- W4380291194 cites W2734273643 @default.
- W4380291194 cites W2751602291 @default.
- W4380291194 cites W2883499425 @default.
- W4380291194 cites W2884209032 @default.
- W4380291194 cites W2888310730 @default.
- W4380291194 cites W2914052093 @default.
- W4380291194 cites W2937441321 @default.
- W4380291194 cites W2943716989 @default.
- W4380291194 cites W2948458637 @default.
- W4380291194 cites W2972246851 @default.
- W4380291194 cites W2981561010 @default.
- W4380291194 cites W3009044721 @default.
- W4380291194 cites W3016649999 @default.
- W4380291194 cites W3024940939 @default.
- W4380291194 cites W3036683952 @default.
- W4380291194 cites W3046273104 @default.
- W4380291194 cites W3049369536 @default.
- W4380291194 cites W3080987600 @default.
- W4380291194 cites W3093671550 @default.
- W4380291194 cites W3093732751 @default.
- W4380291194 cites W3101537665 @default.
- W4380291194 cites W3113706475 @default.
- W4380291194 cites W3133219865 @default.
- W4380291194 cites W3133731390 @default.
- W4380291194 cites W3134594280 @default.
- W4380291194 cites W3157967340 @default.
- W4380291194 cites W3159081741 @default.
- W4380291194 cites W3181458844 @default.
- W4380291194 cites W3188729726 @default.
- W4380291194 cites W3201600715 @default.
- W4380291194 cites W3202603896 @default.
- W4380291194 cites W3210071832 @default.
- W4380291194 cites W3211945524 @default.
- W4380291194 cites W656848795 @default.
- W4380291194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37303667" @default.
- W4380291194 hasPublicationYear "2023" @default.
- W4380291194 type Work @default.
- W4380291194 citedByCount "0" @default.
- W4380291194 crossrefType "journal-article" @default.
- W4380291194 hasAuthorship W4380291194A5031451764 @default.
- W4380291194 hasAuthorship W4380291194A5033632697 @default.
- W4380291194 hasAuthorship W4380291194A5066684292 @default.
- W4380291194 hasAuthorship W4380291194A5071473475 @default.
- W4380291194 hasConcept C104317684 @default.
- W4380291194 hasConcept C119056186 @default.
- W4380291194 hasConcept C121608353 @default.
- W4380291194 hasConcept C126322002 @default.
- W4380291194 hasConcept C142724271 @default.
- W4380291194 hasConcept C143998085 @default.
- W4380291194 hasConcept C2777658100 @default.
- W4380291194 hasConcept C2779013556 @default.
- W4380291194 hasConcept C30345302 @default.
- W4380291194 hasConcept C502942594 @default.
- W4380291194 hasConcept C50382708 @default.
- W4380291194 hasConcept C55493867 @default.
- W4380291194 hasConcept C71924100 @default.
- W4380291194 hasConcept C74864618 @default.
- W4380291194 hasConcept C86803240 @default.
- W4380291194 hasConcept C88634738 @default.
- W4380291194 hasConceptScore W4380291194C104317684 @default.
- W4380291194 hasConceptScore W4380291194C119056186 @default.
- W4380291194 hasConceptScore W4380291194C121608353 @default.
- W4380291194 hasConceptScore W4380291194C126322002 @default.
- W4380291194 hasConceptScore W4380291194C142724271 @default.
- W4380291194 hasConceptScore W4380291194C143998085 @default.
- W4380291194 hasConceptScore W4380291194C2777658100 @default.
- W4380291194 hasConceptScore W4380291194C2779013556 @default.
- W4380291194 hasConceptScore W4380291194C30345302 @default.
- W4380291194 hasConceptScore W4380291194C502942594 @default.
- W4380291194 hasConceptScore W4380291194C50382708 @default.
- W4380291194 hasConceptScore W4380291194C55493867 @default.
- W4380291194 hasConceptScore W4380291194C71924100 @default.
- W4380291194 hasConceptScore W4380291194C74864618 @default.
- W4380291194 hasConceptScore W4380291194C86803240 @default.